65,437 trials
Dental Caries in Children · Pediatric Dental Sedation · Meperidine
Primary: Number of Participants With Successful Sedation — 11; 9 Participants
Type 1 Diabetes Mellitus
Primary: Number of Subjects in Segment 2 With Both a Total Daily Insulin Dose of Less Than 0.5 U/kg/Day and Hemoglobin A1c (HbA1c) Level of Less Than 6.5%. — 41; 14; 22; 20…
Trichiasis · Surgery
Primary: Number of Eyes With Presence of Post-Operative Trichiasis Within 12 Months — 347; 504; 298 eyes — p=0.039
Breast Cancer · Breast Carcinoma · Breast Neoplasms
Primary: Number of Participants According to the Starting Dose of Palbociclib — 99; 43; 1; 2 Participants
Allergic Conjunctivitis · Seasonal Allergies
Primary: Ocular Itching Score at Day 14, 60 Minutes Into the Allergen Challenge — -1.550; -1.013 units on a scale
Alcohol Consumption
Primary: Number of Binge Drinking Days — 2.3; 2.6; 2.9; 3.0 days
Pneumonia Childhood
Primary: Inappropriate Disposition — 7; 6 Participants
Coronary Artery Disease · Healthy Participants
Primary: Percent Change From Baseline in Thrombus Area — 10.0; 538.6; 104.2; -14.9 Percent Change
Cancer · Non Small Cell Lung Cancer Metastatic · Metastatic Melanoma
Primary: Number of Participants Experiencing Dose-limiting Toxicities (DLTs) — 0 Participants
Depressive Disorder, Major
Primary: Change From Baseline in the 17-item HAM-D Total Score at Day 15 — -12.3; -14.1 score on a scale — p=0.0141
Infrarenal Abdominal Aortic Aneurysms · Aortoiliac Aneurysms
Primary: Safety Endpoint: Major Adverse Events (MAEs) — 30 Participants
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
Primary: Recommended Phase II Dose (RP2D) of 8-Chloro-adenosine (8-Cl-Ado) — 400 mg/m^2
Healthy Nutrition
Primary: Effect of Short-term (1-week) Plant- and Animal-based Eating Patterns on Hydrogen Sulfide Production — 69; 103 ppm hydrogen sulfide gas
Breast Cancer
Primary: Progression-free Survival in ESR1-mut Participants — 3.78; 1.87 months — p=0.0005
Adult ALL · Healthy
Primary: Joint Contact Stress-Time Exposure — 3.9; 3.5; 4.1; 2.7 MPa-s/gait cycle